StockData
Impact BioMedical Inc. logo

Impact BioMedical Inc. (IBO) stock

IBONYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.06+0.38 (+14.18%)

Close on Oct 19, 2026Market cap $329.93MP/E –Yield –

Impact BioMedical pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Impact BioMedical's pe ratio was 33.0× on Oct 19, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 202633.0×+31.7
2025Jan 31, 20251.3×+0.2
2024Dec 31, 20241.1×–

More Impact BioMedical figures

See a number that looks wrong?